array(3) { ["company_details"]=> array(13) { ["name"]=> string(24) "Idexx Laboratories, Inc." ["slug"]=> string(31) "52dfe-us-idexx-laboratories-inc" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/adce9a3c-023b-4043-9c56-fbed7dab6f62" ["description"]=> string(1658) "10,000 people, one global focus - enhancing the health and well-being of pets, people, and livestock We are passionate about what we do at IDEXX – and why wouldn’t we be? When you’re working to raise the standard of care for pets, make drinking water safe for billions and keep our livestock population around the globe healthy and free of disease, it’s no wonder that what we do each day is more than just a job. There’s an energy across IDEXX that is contagious – where caring and committed people come together to make things better.  IDEXX Laboratories, Inc. (NASDAQ: IDXX), a member of the S&P 500, is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. Headquartered in southern Maine, we conduct operations through more than 70 locations around the world and serve customers in over 175 countries. Our primary business focuses on pet health, a growing market around the world. Our products —in-clinic diagnostic tests and instrumentation, reference laboratory and telemedicine consultation services, and practice management software—enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices. We also develop and manufacture diagnostic tests and information for the global production animal industry, including poultry and livestock, as well as tests for the quality and safety of water and milk. Please visit our website, IDEXX.com/careers, for further information and to view all of our job opportunities." ["address_street"]=> string(10) "1 Idexx Dr" ["address_place"]=> string(9) "Westbrook" ["address_region"]=> string(5) "Maine" ["founding_date"]=> string(10) "1983-02-28" ["website_domain"]=> string(9) "idexx.com" ["website_url"]=> string(21) "https://www.idexx.com" ["industry_codes"]=> array(4) { [0]=> string(43) "General Livestock, Except Dairy and Poultry" [1]=> string(33) "Veterinary Services for Livestock" [2]=> string(27) "Pharmaceutical Preparations" [3]=> string(42) "In Vitro and In Vivo Diagnostic Substances" } ["employee_count"]=> int(710) ["article_count"]=> int(640) } ["articles"]=> array(9) { [0]=> array(7) { ["title_en"]=> string(76) "IDEXX Laboratories shares cannot maintain previous day's level (€490.9692)" ["snippet_en"]=> string(131) "The shares of IDEXX Laboratories were trading slightly lighter on Thursday. Most recently, investors paid $534.42 for the security." ["url"]=> string(95) "https://www.ariva.de/news/aktie-von-idexx-laboratories-kann-vortagsniveau-nicht-halten-11177664" ["image_url"]=> string(78) "https://images.businessradar.com/articles/7cf0aa94-7659-4b52-bf2f-749377a604e0" ["source"]=> string(8) "ariva.de" ["publication_date"]=> string(10) "2024-03-14" ["categories"]=> array(2) { [0]=> string(12) "Stock Market" [1]=> string(24) "Stock Research & Ratings" } } [1]=> array(7) { ["title_en"]=> string(75) "IDEXX Laboratories Inc. stock outperforms competitors on strong trading day" ["snippet_en"]=> string(160) "Shares of IDEXX Laboratories Inc. inched 0.65% higher to $554.77 Wednesday, on what proved to be an all-around positive trading session for the stock market,..." ["url"]=> string(134) "https://www.marketwatch.com/data-news/idexx-laboratories-inc-stock-outperforms-competitors-on-strong-trading-day-f442fe29-21b7aab24909" ["image_url"]=> string(78) "https://images.businessradar.com/articles/136729fc-81a0-4fc5-be78-c72c4c56f6a4" ["source"]=> string(15) "marketwatch.com" ["publication_date"]=> string(10) "2024-02-21" ["categories"]=> array(3) { [0]=> string(12) "Stock Market" [1]=> string(24) "Stock Research & Ratings" [2]=> string(15) "Market Movement" } } [2]=> array(7) { ["title_en"]=> string(69) "IBD Rating Upgrades: IDEXX Laboratories Shows Improved Price Strength" ["snippet_en"]=> string(114) "A Relative Strength Rating upgrade for IDEXX Laboratories shows improving technical performance. Will it continue?" ["url"]=> string(112) "https://www.investors.com/ibd-data-stories/ibd-rating-upgrades-idexx-laboratories-shows-improved-price-strength/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/a302aa12-ab58-4362-8b74-4d7c045349b6" ["source"]=> string(13) "investors.com" ["publication_date"]=> string(10) "2024-01-26" ["categories"]=> array(3) { [0]=> string(13) "Credit Rating" [1]=> string(24) "Stock Research & Ratings" [2]=> string(19) "Economic Conditions" } } [3]=> array(7) { ["title_en"]=> string(107) "Investors are avoiding the IDEXX Laboratories share today: the price is falling significantly (€491.1639)" ["snippet_en"]=> string(120) "One of the big losers on the stock market today is IDEXX Laboratories shares. The security loses significantly in value." ["url"]=> string(92) "https://www.ariva.de/news/investoren-meiden-heute-die-idexx-laboratories-aktie-kurs-11111817" ["image_url"]=> string(78) "https://images.businessradar.com/articles/383ee36d-3455-4346-97ab-7ac95c8253ef" ["source"]=> string(8) "ariva.de" ["publication_date"]=> string(10) "2024-01-12" ["categories"]=> array(7) { [0]=> string(12) "Stock Market" [1]=> string(24) "Stock Research & Ratings" [2]=> string(9) "Investors" [3]=> string(21) "Shareholders Feedback" [4]=> string(21) "Competitive Behaviour" [5]=> string(18) "General Investment" [6]=> string(15) "Market Movement" } } [4]=> array(7) { ["title_en"]=> string(65) "IDEXX Laboratories Inc. stock rises Wednesday, outperforms market" ["snippet_en"]=> string(157) "Shares of IDEXX Laboratories Inc. inched 0.20% higher to $557.11 Wednesday, on what proved to be an all-around great trading session for the stock market,..." ["url"]=> string(123) "https://www.marketwatch.com/data-news/idexx-laboratories-inc-stock-rises-wednesday-outperforms-market-17bde069-56f16ee2bbe3" ["image_url"]=> string(78) "https://images.businessradar.com/articles/8c5332e9-6512-41af-879f-daec9c1a08de" ["source"]=> string(15) "marketwatch.com" ["publication_date"]=> string(10) "2023-12-27" ["categories"]=> array(4) { [0]=> string(12) "Stock Market" [1]=> string(21) "Competitive Behaviour" [2]=> string(24) "Stock Research & Ratings" [3]=> string(15) "Market Movement" } } [5]=> array(7) { ["title_en"]=> string(64) "IDEXX Laboratories Inc. stock falls Monday, underperforms market" ["snippet_en"]=> string(158) "Shares of IDEXX Laboratories Inc. shed 0.20% to $539.98 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P..." ["url"]=> string(122) "https://www.marketwatch.com/data-news/idexx-laboratories-inc-stock-falls-monday-underperforms-market-ac2fae3b-6b35b7cbea78" ["image_url"]=> string(78) "https://images.businessradar.com/articles/dc0775c3-cbe9-4246-b241-f9c771cc7acb" ["source"]=> string(15) "marketwatch.com" ["publication_date"]=> string(10) "2023-12-18" ["categories"]=> array(3) { [0]=> string(12) "Stock Market" [1]=> string(24) "Stock Research & Ratings" [2]=> string(15) "Market Movement" } } [6]=> array(7) { ["title_en"]=> string(94) "Insider Sell: Executive Vice President James Polewaczyk Sells Shares of IDEXX Laboratories Inc" ["snippet_en"]=> string(224) "In a notable insider transaction, Executive Vice President James Polewaczyk has parted with 11,636 shares of IDEXX Laboratories Inc (NASDAQ:IDXX), a leader in veterinary diagnostics, software, and water microbiology testing." ["url"]=> string(83) "https://finance.yahoo.com/news/insider-sell-executive-vice-president-060504612.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/e3d75832-339c-4bc7-bb5f-f873211b1647" ["source"]=> string(9) "yahoo.com" ["publication_date"]=> string(10) "2023-12-09" ["categories"]=> array(8) { [0]=> string(12) "Stock Market" [1]=> string(24) "Stock Research & Ratings" [2]=> string(10) "Divestment" [3]=> string(15) "Insider Trading" [4]=> string(12) "Board Change" [5]=> string(14) "Issuing Shares" [6]=> string(20) "Corporate Governance" [7]=> string(10) "Executives" } } [7]=> array(7) { ["title_en"]=> string(55) "IDEXX Laboratories Stock Earns IBD Stock Rating Upgrade" ["snippet_en"]=> string(124) "On Wednesday, IDEXX Laboratories now stock clears the 80-plus Relative Strength Rating threshold, with a jump from 79 to 83." ["url"]=> string(87) "https://www.investors.com/news/idexx-laboratories-stock-earns-ibd-stock-rating-upgrade/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/f1554980-231c-484d-9fde-e17dc6859c78" ["source"]=> string(13) "investors.com" ["publication_date"]=> string(10) "2023-12-06" ["categories"]=> array(4) { [0]=> string(13) "Credit Rating" [1]=> string(12) "Stock Market" [2]=> string(24) "Stock Research & Ratings" [3]=> string(24) "Systemic Risk Management" } } [8]=> array(7) { ["title_en"]=> string(66) "IDEXX Laboratories shares with significant price gains (€474.70)" ["snippet_en"]=> string(208) "The shares of IDEXX Laboratories are currently shining on the US stock exchange. The title rose significantly in price on Monday. An increase of 7.01 percent - with this increase in value the security belongs" ["url"]=> string(134) "https://www.finanznachrichten.de/nachrichten-2023-12/60833089-idexx-laboratories-aktie-mit-deutlichen-kursgewinnen-474-70-euro-013.htm" ["image_url"]=> string(78) "https://images.businessradar.com/articles/d8883a32-e80e-45be-9f29-5700ab7e39ed" ["source"]=> string(20) "finanznachrichten.de" ["publication_date"]=> string(10) "2023-12-04" ["categories"]=> array(6) { [0]=> string(12) "Stock Market" [1]=> string(12) "Going Public" [2]=> string(16) "Share Repurchase" [3]=> string(24) "Stock Research & Ratings" [4]=> string(14) "Issuing Shares" [5]=> string(15) "Market Movement" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(117) } [1]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(65) } [2]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(43) } [3]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(43) } [4]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(40) } [5]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(24) } [6]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(22) } [7]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(22) } [8]=> array(2) { ["name"]=> string(12) "Restatements" ["count"]=> int(21) } [9]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(19) } [10]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(18) } [11]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(16) } [12]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(14) } [13]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(12) } [14]=> array(2) { ["name"]=> string(11) "Regulations" ["count"]=> int(9) } [15]=> array(2) { ["name"]=> string(9) "Investors" ["count"]=> int(9) } [16]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(8) } [17]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(8) } [18]=> array(2) { ["name"]=> string(31) "Water and Wastewater Management" ["count"]=> int(7) } [19]=> array(2) { ["name"]=> string(16) "Share Repurchase" ["count"]=> int(7) } [20]=> array(2) { ["name"]=> string(19) "Economic Conditions" ["count"]=> int(7) } [21]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(7) } [22]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(7) } [23]=> array(2) { ["name"]=> string(13) "Credit Rating" ["count"]=> int(6) } [24]=> array(2) { ["name"]=> string(10) "New Market" ["count"]=> int(6) } [25]=> array(2) { ["name"]=> string(5) "Event" ["count"]=> int(5) } [26]=> array(2) { ["name"]=> string(15) "Blogs & Columns" ["count"]=> int(5) } [27]=> array(2) { ["name"]=> string(11) "Competition" ["count"]=> int(5) } [28]=> array(2) { ["name"]=> string(20) "Corporate Governance" ["count"]=> int(5) } [29]=> array(2) { ["name"]=> string(12) "Going Public" ["count"]=> int(5) } } } 52dfe-us-idexx-laboratories-inc